Leta i den här bloggen

måndag 13 oktober 2025

Rokotteen POXvirus VACV ilmentää immunomodulatorisia proteiineja kuten BTB-BACK-Kelch-kaltaisia(BBK) proteiineja. Muita POX viruksia ja niiden koodaamia proteiineja

 1.2 LSDV  cluster 

28 results

Genomic Analysis of Lumpy Skin Disease Virus from Western and Central Africa Suggests a Distinct Sub-Lineage Within the 1.2 LSDV Cluster.
Fadele J, Ogunsanya O, Adedokun O, Ayinla A, Pami M, Sijuwola A, Saibu F, Soumare H, Fanou U, Brown C, Faburay B, Happi C, Happi A. Pathogens. 2025 Sep 12;14(9):922. doi: 10.3390/pathogens14090922. PMID: 41011822 Free PMC article.
Phylogenetic evaluation revealed that LSDV strains from Nigeria and Cameroon cluster within the classical 1.2 lineage. Furthermore, the two sequences from this study cluster with the only publicly available sequence from West and Central Africa, supporting earlier findings of the presence of a West/Central African sub-lineage. Functional genomic analysis identified mutations in genes encoding ankyrin repeat Kelch-like proteins, and envelope proteins involved in immune evasion and viral virulence, raising concerns about vaccine effectiveness. Furthermore, the detection of LSDV in flesh flies (Sarcophaga spp.) underlines their potential role in virus transmission. These findings highlight the importance of genomic monitoring and targeted surveillance.toistoisia KELCH-proteiinien kaltaisia 
Genetic Evolutionary Analysis of Lumpy Skin Disease Virus Strain Under Immune Pressure Exerted by Heterologous Goat Poxvirus Vaccines.
Chang W, Fang J, Zhai T, Han S, Fan W, Lei C, Wang L, Qi X, Xue Q, Wang J. Transbound Emerg Dis. 2025 Feb 23;2025:2883245. doi: 10.1155/tbed/2883245. eCollection 2025. PMID: 40302761 Free PMC article.
Recently, LSD has occurred frequently in Asia. The attenuated goat poxvirus (GTPV) vaccine is widely used to prevent LSD in cattle in China; however, sporadic cases of LSD still occur in immunized cattle. ...There are several open reading frames (ORFs) differences between …
Genomic characterization of Lumpy Skin Disease virus (LSDV) from India: Circulation of Kenyan-like LSDV strains with unique kelch-like proteins.
Kumar A, Venkatesan G, Kushwaha A, Poulinlu G, Saha T, Ramakrishnan MA, Dhar P, Kumar GS, Singh RK. Acta Trop. 2023 May;241:106838. doi: 10.1016/j.actatropica.2023.106838. Epub 2023 Feb 15. PMID: 36796571
Phylogenetic analysis based on complete genome sequence suggested that LSDV-WB/IND/19 is closely related to Kenyan LSDV strains with 10-12 variants with non-synonymous changes confined to LSD_019, LSD_049, LSD_089, LSD_094, LSD_096, LSD_140, and LSD_144 genes. In contrast to comp …
Emergence of a new lumpy skin disease virus variant in Kurgan Oblast, Russia, in 2018.
Aleksandr K, Pavel P, Olga B, Svetlana K, Vladimir R, Yana P, Alexander S. Arch Virol. 2020 Jun;165(6):1343-1356. doi: 10.1007/s00705-020-04607-5. Epub 2020 Apr 11. PMID: 32279139
Due to these incongruent phylogenetic patterns, the sequences of three additional loci ORF19 (Kelch-like protein), ORF52 (putative transcriptional elongation factor), and ORF87 (mutT motif protein) were investigated. ...
Kelch-like proteins: Physiological functions and relationships with diseases.
Shi X, Xiang S, Cao J, Zhu H, Yang B, He Q, Ying M. Pharmacol Res. 2019 Oct;148:104404. doi: 10.1016/j.phrs.2019.104404. Epub 2019 Aug 20. PMID: 31442578 Review.
Kelch-like gene family members (KLHLs) encode proteins with a bric-a-brac, tramtrack, broad complex (BTB)/poxvirus and zinc finger (POZ) domain, a BACK domain, and six Kelch motifs, which frequently interact with Cullin3 to form E3 ligase complexes tha
Extended sequencing of vaccine and wild-type capripoxvirus isolates provides insights into genes modulating virulence and host range.
Biswas S, Noyce RS, Babiuk LA, Lung O, Bulach DM, Bowden TR, Boyle DB, Babiuk S, Evans DH. Transbound Emerg Dis. 2020 Jan;67(1):80-97. doi: 10.1111/tbed.13322. Epub 2019 Aug 30. PMID: 31379093
The genus Capripoxvirus in the subfamily Chordopoxvirinae, family Poxviridae, comprises sheeppox virus (SPPV), goatpox virus (GTPV) and lumpy skin disease virus (LSDV), which cause the eponymous diseases across parts of Africa, the Middle East and Asia. ...In particular, s …
Vaccinia Virus BBK E3 Ligase Adaptor A55 Targets Importin-Dependent NF-κB Activation and Inhibits CD8+ T-Cell Memory.
Pallett MA, Ren H, Zhang RY, Scutts SR, Gonzalez L, Zhu Z, Maluquer de Motes C, Smith GL. J Virol. 2019 May 1;93(10):e00051-19. doi: 10.1128/JVI.00051-19. Print 2019 May 15. PMID: 30814284 Free PMC article.

Viral infection of cells is sensed by pathogen recognition receptors that trigger an antiviral innate immune response, and consequently viruses have evolved countermeasures. Vaccinia virus (VACV) evades the host immune response by expressing scores of immunomodulatory proteins. One family of VACV proteins are the BTB-BACK (broad-complex, tram-trac, and bric-a-brac [BTB] and C-terminal Kelch [BACK]) domain-containing, Kelch-like (BBK) family of predicted cullin-3 E3 ligase adaptors: A55, C2, and F3. Previous studies demonstrated that gene A55R encodes a protein that is nonessential for VACV replication yet affects viral virulence in vivo Here, we report that A55 is an NF-κB inhibitor acting downstream of IκBα degradation, preventing gene transcription and cytokine secretion in response to cytokine stimulation. A55 targets the host importin α1 (KPNA2), acting to reduce p65 binding and its nuclear translocation. Interestingly, while A55 was confirmed to coprecipitate with cullin-3 in a BTB-dependent manner, its NF-κB inhibitory activity mapped to the Kelch domain, which alone is sufficient to coprecipitate with KPNA2 and inhibit NF-κB signaling. Intradermal infection of mice with a virus lacking A55R (vΔA55) increased VACV-specific CD8+ T-cell proliferation, activation, and cytotoxicity in comparison to levels of the wild-type (WT) virus. Furthermore, immunization with vΔA55 induced increased protection to intranasal VACV challenge compared to the level with control viruses. In summary, this report describes the first target of a poxvirus-encoded BBK protein and a novel mechanism for DNA virus immune evasion, resulting in increased CD8+ T-cell memory and a more immunogenic vaccine.

IMPORTANCE NF-κB is a critical transcription factor in the innate immune response to infection and in shaping adaptive immunity. The identification of host and virus proteins that modulate the induction of immunological memory is important for improving virus-based vaccine design and efficacy. In viruses, the expression of BTB-BACK Kelch-like (BBK) proteins is restricted to poxviruses and conserved within them, indicating the importance of these proteins for these medically important viruses. Using vaccinia virus (VACV), the smallpox vaccine, we report that the VACV BBK protein A55 dysregulates NF-κB signaling by disrupting the p65-importin interaction, thus preventing NF-κB translocation and blocking NF-κB-dependent gene transcription. Infection with VACV lacking A55 induces increased VACV-specific CD8+ T-cell memory and better protection against VACV challenge. Studying viral immunomodulators therefore expands not only our understanding of viral pathogenesis and immune evasion strategies but also of the immune signaling cascades controlling antiviral immunity and the development of immune memory.

Keywords: BTB-Kelch; E3 ligase; NF-κB; cullin-3; importins; protein A55; vaccinia virus.

VARV B22R homologue as phylogenetic marker gene for Capripoxvirus classification and divergence time dating.
Mishra B, Mondal P, Patel CL, Zafir I, Gangwar R, Singh N, Sonowal J, Bisht D, Sahu AR, Baig M, Sajjanar B, Singh RK, Gandham RK. Virus Genes. 2019 Feb;55(1):51-59. doi: 10.1007/s11262-018-1613-9. Epub 2018 Nov 16. PMID: 30446925
…Sheeppox disease is associated with significant losses in sheep production world over. The sheep pox virus, the goatpox virus, and the lumpy skin disease virus cannot be distinguished by conventional serological tests. Identification of these pathogens needs molecular methods. In this study, seven genes viz. EEV maturation protein-F12L, Virion protein-D3R, RNA polymerase subunit-A5R, Virion core protein-A10L, EEV glycoprotein-A33R, VARV B22R homologue, and Kelch like protein-A55R that cover the start, middle, and end of the genome were selected. These genes were amplified from Roumanian-Fanar vaccine strain and Jaipur virulent strain, cloned, and sequenced. On analysis with the available database sequences, VARV B22R homologue was identified as a marker for phylogenetic reconstruction for classifying the sheeppox viruses of the ungulates. Further, divergence time dating with VARV B22R gene accurately predicted the sheeppox disease outbreak involving Jaipur virulent strain.
Isolation and genetic characterization of swinepox virus from pigs in India.
Riyesh T, Barua S, Kumar N, Jindal N, Bera BC, Narang G, Mahajan NK, Arora D, Anand T, Vaid RK, Yadav M, Chandel SS, Malik P, Tripathi BN, Singh RK. Comp Immunol Microbiol Infect Dis. 2016 Jun;46:60-5. doi: 10.1016/j.cimid.2016.04.001. Epub 2016 Apr 4. PMID: 27260812 Keywords: Ankyrin- repeat protein; Extracellular enveloped protein; Host-range genes; Kelch-like protein; Swinepox virus.
Klhl31 attenuates β-catenin dependent Wnt signaling and regulates embryo myogenesis.
Abou-Elhamd A, Alrefaei AF, Mok GF, Garcia-Morales C, Abu-Elmagd M, Wheeler GN, Münsterberg AE. Dev Biol. 2015 Jun 1;402(1):61-71. doi: 10.1016/j.ydbio.2015.02.024. Epub 2015 Mar 19. PMID: 25796573 Free article.
Klhl31 is a member of the Kelch-like family in vertebrates, which are characterized by an amino-terminal broad complex tram-track, bric-a-brac/poxvirus and zinc finger (BTB/POZ) domain, carboxy-terminal Kelch repeats and a central linker region (Back domain). … Klhl31 interferes with β-catenin dependent Wnt signaling. Klhl31 reduced the Wnt-mediated activation of a luciferase reporter in cultured cells. Furthermore, Klhl31 attenuated secondary axis formation in Xenopus embryos in response to Wnt1 or β-catenin. Klhl31 mis-expression in the developing neural tube affected its dorso-ventral patterning and led to reduced dermomyotome and myotome size. Co-transfection of a Wnt3a expression vector with Klhl31 in somites or in the neural tube rescued the phenotype and restored the size of dermomyotome and myotome. Thus, Klhl31 is a novel modulator of canonical Wnt signaling, important for vertebrate myogenesis. We propose that Klhl31 acts in the myotome to support cell cycle withdrawal and differentiation.

POXvirusproteiineissa on paljon ankyriini(ANK) toistojaksoja omaavia proteiineja, joilla on virulenssille merkitystä

 https://www.pnas.org/doi/full/10.1073/pnas.0802042105

ANK proteins constitute the largest family of poxviral proteins but their function and the significance of their abundance have remained an enigma. We propose that poxviruses use these unique ANK/F-box proteins to dictate target specificity to SCF1 ubiquitin ligases and thereby exploit the cell's ubiquitin-proteasome machinery. 

MPXV

doi: 10.1128/spectrum.03199-22. Online ahead of print. Unique Tandem Repeats in the Inverted Terminal Repeat Regions of Monkeypox Viruses
Affiliations
Abstract

The genetic diversity, especially in noncoding regions between clade I, clade IIa, and clade IIb monkeypox viruses (MPXVs), is still not fully understood. Here, we report that unique 16-nucleotide-length tandem repeats in MPXVs viruses are located in the noncoding regions of inverted terminal repeats (ITR), and the copy number of this repeat is different among clade I, clade IIa, and clade IIb viruses. It is noteworthy that tandem repeats containing these specific sequences (AACTAACTTATGACTT) are only present in MPXVs and are not found in other poxviruses. Also, the tandem repeats containing these specific sequences (AACTAACTTATGACTT) do not correspond to the tandem repeats present in the human and rodent (mice and rat) genomes. On the other hand, some of the reported tandem repeats in the human and rodent (mice and rat) genomes are present in the clade IIb-B.1 lineage of MPXV. In addition, it is noteworthy that the genes flanking these tandem repeats are lost and gained compared between clade I, clade IIa, and clade IIb MPXV. IMPORTANCE The different groups of MPXVs contain unique tandem repeats with different copy numbers in the ITR regions, and these repeats may be likely to play a role in the genetic diversity of the virus. Clade IIb (B) MPXV contains 38 and 32 repeats similar to the Tandem repeats reported in the human and rodent genome, respectively. However, none of these 38 (human) and 32 (rodent) tandem repeats matched the tandem repeats (AACTAACTTATGACTT) found in the present study. Finally, when developing attenuated or modified MPXV vaccine strains, these repeats in noncoding genomic regions can be exploited to incorporate foreign proteins (adjuvants/other virus proteins/racking fluorescent proteins such as green fluorescent protein) to carry out studies such as vaccine production and virus pathogenesis.

Keywords: adaptive evolution; horizontal gene transfer; monkeypox; multicountry outbreak 2022; tandem repeats; transposon.

PubMed Disclaimer


söndag 12 oktober 2025

KEAP1-NRF2 ja HIF1a. PubMed haku, 4 vastausta

 

NRF2 and Hypoxia-Inducible Factors: Key Players in the Redox Control of Systemic Iron Homeostasis.
Duarte TL, Talbot NP, Drakesmith H. Antioxid Redox Signal. 2021 Aug 20;35(6):433-452. doi: 10.1089/ars.2020.8148. Epub 2020 Nov 10. PMID: 32791852 Review.
This review analyzes the roles of key oxygen-sensing pathways in cellular and systemic regulation of iron homeostasis; specifically, the prolyl hydroxylase domain (PHD)/hypoxia-inducible factor (HIF) and the Kelch-like ECH-associated protein 1/NF-E2 p45-related factor 2 (KEAP1
KEAP1-NRF2 complex in ischemia-induced hepatocellular damage of mouse liver transplants.
Ke B, Shen XD, Zhang Y, Ji H, Gao F, Yue S, Kamo N, Zhai Y, Yamamoto M, Busuttil RW, Kupiec-Weglinski JW. J Hepatol. 2013 Dec;59(6):1200-7. doi: 10.1016/j.jhep.2013.07.016. Epub 2013 Jul 16. PMID: 23867319 Free PMC article.
BACKGROUND & AIMS: The Keap1-Nrf2 signaling pathway regulates host cell defense responses against oxidative stress and maintains the cellular redox balance. METHODS: We investigated the function/molecular mechanisms by which Keap1-Nrf2 complex may …

SVA tieto eläinten ihopahkurataudista, lumpy skin disease

 

ANMÄLNINGSPLIKTIG SJUKDOM EPIZOOTISJUKDOM

Lumpy skin disease orsakas av ett poxvirus och är närbesläktat med får- och getkoppor. Nötkreatur är det enda tamdjur som kan drabbas.

Förekomst;  Lumpy skin disease förekommer endemiskt i stora delar av Afrika, och har sedan flera år etablerat sig i Mellanöstern, Turkiet och Ryssland. Under 2015 rapporterades utbrott av Lumpy skin disease från Grekland, vilket var det första fallet av sjukdomen i EU. Året efter (2016) hade sjukdomen spridit sig till omkringliggande länder (Bulgarien, Nordmakedonien, Serbien, Montenegro, Albanien och Kosovo) och det rapporterades över 1 000 utbrott från dessa länder i sydöstra Europa. Sjukdomen bekämpades med hjälp av massvaccinering, och inga utbrott har rapporterats i de drabbade länderna sedan 2018. Under 2025 har utbrott rapporterats från Italien och Frankrike. Sjukdomen har aldrig påvisats i Sverige.
 
Symtom:Nötkreatur i alla åldrar insjuknar, men unga individer drabbas oftast hårdast. Den kliniska bilden hos nötkreatur varierar, alltifrån dödsfall till enstaka hudutslag utan övriga symtom. I fall med tydliga symtom ses knappformiga, runda hudutslag inom 48 timmar efter en inledande feberstegring. Utslagen kan uppkomma över hela kroppen, alltifrån några enstaka till flera hundra. Djuren blir allmänpåverkade, aptitlösa och får ödem på buk, ben och i dröglapp. Beroende på var utslagen sitter kan till exempel ögon- och nosflöde samt ökad salivering ses. Kopporna kan bli infekterade och bilda bölder. Normalt läker hudförändringarna först efter flera månader och ger bestående ärrbildning. Hudarna blir därför i praktiken värdelösa.
Smittämne; Sjukdomen orsakas av ett poxvirus (virussläktet 
 
Inkubationstid: Inkubationstiden är två till fyra veckor.
Smittvägar: Sjukdomen smittar främst med vektorer såsom flugor, myggor och andra bitande insekter. Direktsmitta mellan djur förekommer också.
Diagnos: Det snabbaste sättet att bekräfta diagnosen är påvisande av virusgenom i hudlesioner eller inre organ med PCR. Virusisolering och elektronmikroskopering av material från hudlesioner på det drabbade djuret är också säkra metoder för att påvisa virus.  I länder där smittan normalt inte förekommer kan påvisande av antikroppar också användas, men det går inte att skilja på antikroppar mot andra capripoxvirus, det vill säga de virus som orsakar får- och getkoppor. Serologi kan också användas i övervakningssyfte.
Om man misstänker sjukdomen: Lumpy skin disease lyder under

I Veterinära författningshandboken kan du läsa mer om den lagstiftning som gäller vid epizootisjukdomar.

Läs mer hos andra : Europeiska myndigheten för livsmedelssäkerhet (Efsa): Lumpy skin disease

https://www.woah.org/en/disease/lumpy-skin-disease/ 

 

Tuhkarokkovirus.

 https://pubmed.ncbi.nlm.nih.gov/41016799/

Review
. 2025;75(1):13-22.
doi: 10.2222/jsv.75.13. [Measles virus]
[Article in Japanese]
Affiliations
Abstract

Measles virus is the pathogen that causes measles and is highly infectious. Measles virus uses two molecules as viral receptors: signaling lymphocytic activation molecule, expressed on immune cells, and nectin-4, expressed on epithelial cells. Usage of these receptors is strongly associated with the pathogenesis of measles. Although it remains a leading cause of childhood mortality worldwide, measles elimination is being promoted by the availability of a highly effective live attenuated vaccines. Due to the elimination of measles in many countries, the circulating measles genotypes have been reduced to two, B3 and D8, in recent years. Therefore, in addition to genotyping using the conventional 450-nucleotide N gene region, new methods such as wholegenome sequencing and analysis of the M-F non-coding region are being tested for case association and outbreak tracking. Although measles virus is a single serotype, there are genomic differences among genotypes, including variations in B-cell and T-cell epitopes. However, current live attenuated vaccines remain sufficiently effective against all genotypes. On the other hand, the maintenance of protective immunity in vaccinees may become increasingly important, since vaccine-induced immunity tends to wane over time unlike the more durable immunity following natural infection.

 https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&id=11234

Measles morbillivirus
equivalent:
subacute sclerosing panencephalitis virus, SSPEV
Subacute sclerosing panencephalitis virus
Cell-associated subacute sclerosing panencephalitis
measles virus MV
rougeole virus
rubeola virus
subacute sclerose panencephalitis virus
Measles virus
measles

fredag 10 oktober 2025

POXVIRUKSET: LSDV ja muita POX-viruksia ...

 

Genome of Lumpy Skin Disease Virus


PMCID: PMC114441  PMID: 11435593

Abstract

Lumpy skin disease virus (LSDV), a member of the capripoxvirus genus of the Poxviridae, is the etiologic agent of an important disease of cattle in Africa. Here we report the genomic sequence of LSDV. The 151-kbp LSDV genome consists of a central coding region bounded by identical 2.4 kbp-inverted terminal repeats and contains 156 putative genes. Comparison of LSDV with chordopoxviruses of other genera reveals 146 conserved genes which encode proteins involved in transcription and mRNA biogenesis, nucleotide metabolism, DNA replication, protein processing, virion structure and assembly, and viral virulence and host range. In the central genomic region, LSDV genes share a high degree of colinearity and amino acid identity (average of 65%) with genes of other known mammalian poxviruses, particularly suipoxvirus, yatapoxvirus, and leporipoxviruses. In the terminal regions, colinearity is disrupted and poxvirus homologues are either absent or share a lower percentage of amino acid identity (average of 43%). Most of these differences involve genes and gene families with likely functions involving viral virulence and host range. Although LSDV resembles leporipoxviruses in gene content and organization, it also contains homologues of interleukin-10 (IL-10), IL-1 binding proteins, G protein-coupled CC chemokine receptor, and epidermal growth factor-like protein which are found in other poxvirus genera. These data show that although LSDV is closely related to other members of the Chordopoxvirinae, it contains a unique complement of genes responsible for viral host range and virulence.

Capripoxviruses (CaPVs) represent one of eight genera within the chordopoxvirus (ChPV) subfamily of the Poxviridae.

 The capripoxvirus genus is currently comprised of 
 lumpy skin disease virus (LSDV),  
 sheeppox virus (ShPV), and 
 goatpox virus (GPV)
 
capra, goat, Bovidae 
sheep (Ovis), Bovidae
 Goat, capra, Bovidae 

These viruses are responsible for some of the most economically significant diseases of domestic ruminants in Africa and Asia (). CaPV infections are generally host specific and they have specific geographic distributions (, , ). CaPVs are, however, serologically indistinguishable from each other, able to induce heterologous cross-protection, and able in some instances to experimentally cross-infect (, , , ). Restriction fragment analysis and limited DNA sequence data support a close relationship between CaPVs (, , , ). The molecular basis of CaPV host range restriction and virulence remains to be elucidated.

LSD is a subacute to acute cattle disease in Africa. It is characterized by extensive cutaneous lesions and signs typical of generalized poxvirus diseases (, ). Transmission of LSD between cattle is inefficient, and arthropod-vectored transmission may be significant in epizootic outbreaks and in the spread of LSD into nonenzootic regions (, , , , ).

 Attenuated LSDV strains and ShPV have been successfully used as LSD vaccines in enzootic and outbreak areas; however, vaccine failure and restrictions on the use of live virus vaccines create the need for a safe and effective, live attenuated vaccine (, , , ).

 Current molecular data on the LSDV genome consists of restriction endonuclease analysis, cross-hybridization studies, and limited transcriptional and DNA sequence analysis (, , , , , ). Given the economic significance of LSD, its potential for spread into nonenzootic regions, and the interest in developing more effective LSDV-based vaccines and expression vectors, we have sequenced and analyzed the genome of a pathogenic LSDV. These data provide the first view of a CaPV genome, and they define the gene complement that underlies LSDV virulence and host range.

--- 

LSDV contains 156 ORFs which have been annotated here as putative genes. These genes represent a 95% coding density and encode proteins of 53 to 2,025 amino acids (Fig. 1, Table 1). Similar to other poxviruses, many of the 41 putative early genes are members of gene families and/or putative host range genes, while the 46 genes containing the VV late promoter sequence (TAAATG) at the ATG codon () include many of the conserved virion-associated poxviral genes (Table 1).  

 Otan vain yhden proteiinin rrakenteen, siin on KELCH-proteiinin rakenne selvittettynä, propellit
 

ecName: Full=Protein C13

UniProtKB/Swiss-Prot: P32206.1

Identical Proteins FASTA Graphics 

LOCUS       VC13_SWPVK               500 aa            linear   VRL 05-FEB-2025
DEFINITION  RecName: Full=Protein C13.
ACCESSION   P32206
VERSION     P32206.1
DBSOURCE    UniProtKB: locus VC13_SWPVK, accession P32206;
            class: standard.
            created: Oct 1, 1993.
            sequence updated: Oct 1, 1993.
            annotation updated: Feb 5, 2025.
            xrefs: L22013.1, AAC37858.1
            xrefs (non-sequence databases): SMR:P32206, Gene3D:1.25.40.420,
            Gene3D:2.120.10.80, Gene3D:3.30.710.10, InterPro:IPR011705,
            InterPro:IPR000210, InterPro:IPR015915, InterPro:IPR006652,
            InterPro:IPR011333, PANTHER:PTHR24412, PANTHER:PTHR24412:SF489,
            Pfam:PF07707, Pfam:PF00651, Pfam:PF01344, SMART:SM00875,
            SMART:SM00225, SMART:SM00612, SUPFAM:SSF117281, SUPFAM:SSF54695,
            PROSITE:PS50097
KEYWORDS    Kelch repeat; Repeat.
SOURCE      Swinepox virus (STRAIN KASZA)
  ORGANISM  Swinepox virus (STRAIN KASZA)
            Viruses; Varidnaviria; Bamfordvirae; Nucleocytoviricota;
            Pokkesviricetes; Chitovirales; Poxviridae; Chordopoxvirinae;
            Suipoxvirus; Suipoxvirus swinepox.
REFERENCE   1  (residues 1 to 500)
  AUTHORS   Massung,R.F., Jayarama,V. and Moyer,R.W.
  TITLE     DNA sequence analysis of conserved and unique regions of swinepox
            virus: identification of genetic elements supporting phenotypic
            observations including a novel G protein-coupled receptor homologue
  JOURNAL   Virology 197 (2), 511-528 (1993)
   PUBMED   8249275
  REMARK    NUCLEOTIDE SEQUENCE.
COMMENT     [SIMILARITY] Belongs to the poxviruses Kelch family. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..500
                     /organism="Swinepox virus (STRAIN KASZA)"
                     /host="Sus scrofa (Pig)"
                     /db_xref="taxon:10277"
     gene            1..500
                     /locus_tag="C13L"
     Protein         1..500
                     /product="Protein C13"
                     /UniProtKB_evidence="Inferred from homology"
     Region          1..500
                     /region_name="Mature chain"
                     /note="Protein C13. /id=PRO_0000119169."
     Region          17..500
                     /region_name="PHA03098"
                     /note="kelch-like protein; Provisional"
                     /db_xref="CDD:222983"
     Region          27..89
                     /region_name="Domain"
                     /note="BTB.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU00037."
     Region          301..348
                     /region_name="Repetitive region"
                     /note="Kelch 1."
     Region          338..381
                     /region_name="KELCH repeat"
                     /note="KELCH repeat [structural motif]"
                     /db_xref="CDD:276965"
     Region          349..395
                     /region_name="Repetitive region"
                     /note="Kelch 2."
     Region          385..427
                     /region_name="KELCH repeat"
                     /note="KELCH repeat [structural motif]"
                     /db_xref="CDD:276965"
     Region          397..440
                     /region_name="Repetitive region"
                     /note="Kelch 3."
     Region          430..477
                     /region_name="KELCH repeat"
                     /note="KELCH repeat [structural motif]"
                     /db_xref="CDD:276965"
     Region          441..490
                     /region_name="Repetitive region"
                     /note="Kelch 4."
ORIGIN      
        1 mskqetyidy nyierlnavn lnrsydeeiv fimtvggvvk vkkellvsvs nyfklitknq
       61 sneitvsfqy esfldiikyi etgivtidld nvenifsisc skaidflkns cidfmskhit
      121 dstcvkiyki gfsngcfavy ndaiayirkr ftkietdill slslfdlrii lksgeldvss
      181 eddvllfiik wsrhkksnrr ksftlvtevl rynylsiygk ykltkwlarf gknnnvelne
      241 nelprisyqh rftnrrytmv tpssfsinml gnvsvknels iinsiaenhn pycgsvlmnd
      301 ilyliggink sldpvsdits vdtrsfielh tppllhprkc pgvaifknri yvvggigydg
      361 plktveswsp geqqwreevp llqprfnpci igtdndlyvv ggiseddkti eiysyeentw
      421 signamnysh fggciayhhg yiymigglsf idnihvftmv ekynphsnkw tvekslpfpr
      481 fnsslciied siaiigwiyy
//
  • LSDV eläinten virustauti genus Capripoxvirus,Chordopoxvirinae, Poxviridae Chitovirales, Pokkesviricetes , Nucleocytoviricota, Bamfordvirae Varidnaviria

     Tämä virus käyttää KELCH-proteiiniraknnetta  edukseen 

    Clinical signs:

    Clinical signs vary, with younger animals more severely affected.

    • Nodular skin lesions (lumps) on the animal’s body, muzzle, nose, head, neck, back, legs, scrotum, perineum, udder, eyelids, tail and mouth
    • Nodules can also develop internally, particularly in the respiratory and gastrointestinal tracts
    • Fever
    • Listlessness and reluctance to eat
    • Ocular and nasal discharge
    • Milk drop with weight loss
    Virology Taxonomy
    Realm Varidnaviria
    kingdom Bamfordvirae
    phylum Nucleocytoviricota,
     class Pokkesviricetes
    order Chitovirales
    family Poxviridae,
     subfamily Chordopoxvirinae,
     genus Capripoxvirus, 
    species Lumpy skin disease virus, LSDV
    Virion: LSDV virion displays a typical poxvirus morphology: brick-shaped virions (220-450 long × 140-260 wide × 140-260 nm thick). Virions consist of a lipoprotein surface membrane enclosing a biconcave core that contains the DNA genome. Two lateral bodies are present in the concave regions between the core and the membrane.
    Genome: The LSDV genome is a linear molecule of dsDNA,151,000 base pairs (bp) in length, with covalently-closed ends. The viral genome encodes 156 putative genes and is organized in a central region flanked by identical inverted terminal repeats of ~2,400 bp each.
    Lifecycle: Virus entry is mediated by fusion between viral and cellular membranes at the plasma membrane or following endocytosis. 
    The early phase of replication includes expression of proteins needed for replication of viral DNA and modulation of the host cellular functions and antiviral defences. 
    DNA replication and gene expression occur in the cytoplasm in ‘virus factories’ and is mediated by virus-encoded proteins. 
    The late phase of replication includes the expression of structural proteins involved in the multistage assembly of new virions. Virions are released by exocytosis or after cell lysis. 
     
     Abstract Lumpy Skin Disease Virus (LSDV) is a transboundary pathogen that affects cattle, causing significant economic losses, particularly in Africa and Asia. While the virus was originally endemic to sub-Saharan Africa, it has rapidly spread to Europe, the Middle East, and Asia, necessitating comprehensive genomic surveillance. 
    Despite LSDV's African origins, genomic data from West and Central Africa remain scarce, limiting insights into regional viral evolution and vaccine compatibility.
     In this study, molecular detection of LSDV was carried out on cattle samples from Nigeria, Cameroon, and Benin. However, comparative genomic analysis was performed using two near-complete LSDV genomes obtained from Cameroon.
     Phylogenetic evaluation revealed that LSDV strains from Nigeria and Cameroon cluster within the classical 1.2 lineage. Furthermore, the two sequences from this study cluster with the only publicly available sequence from West and Central Africa, supporting earlier findings of the presence of a West/Central African sub-lineage.
     Functional genomic analysis identified mutations in genes encoding ankyrin repeat Kelch-like proteins, and envelope proteins involved in immune evasion and viral virulence, raising concerns about vaccine effectiveness.
     Furthermore, the detection of LSDV in flesh flies (Sarcophaga spp.) underlines their potential role in virus transmission. 
    These findings highlight the importance of genomic monitoring and targeted surveillance.

    Keywords: Africa; Kelch-like proteins; Lumpy Skin Disease Virus (LSDV); SNP mutations; ankyrin repeat proteins; genomic analysis; phylogenetic analysis; poxviruses; vaccine efficacy; vector transmission.

     

    torsdag 9 oktober 2025

    Ruotsin Kansanterveysvirast seuraa Kongon ebolaepidemian kesättelyä

     https://www.folkhalsomyndigheten.se/smittskydd-beredskap/utbrott/aktuella-utbrott/ebola-demokratiska-republiken-kongo-september-2025/

    Mitä Lancet kirjoittaa Kongon ebolapurkauksesta?

     

    CorrespondenceOnline firstOctober 03, 2025
    New Ebola virus disease outbreak in the Democratic Republic of the Congo: early response guidance

    https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01950-6/fulltext?rss=yes

     

    On Sept 4, 2025, in line with International Health Regulations (2005) requirements, the Minister of Health of the Democratic Republic of the Congo officially declared a new Ebola virus disease outbreak in Kasai province, affecting the health zone of Bulape. This new outbreak of Ebola virus disease has occurred in a fragile context, regionally and globally, as the Democratic Republic of the Congo is responding to an ongoing complex humanitarian situation, as well as outbreaks of cholera, mpox, and measles. The African region, as a whole, is adversely affected by the current global financial and geopolitical challenges. These external factors are likely to strain response measures in an already fragile situation, making decisive, rapid response by all actors—regional and international—of particular importance.
    Ebola virus disease represents a major public health risk due to the potential for international spread and high case-fatality rate, varying between 25% and 90%. Experience of the Ebola virus disease outbreak of 2014–16 in west Africa showed that, while the disease was initially assumed to occur only in isolated areas of central Africa, spread from rural to urban areas can occur, with substantial socioeconomic consequences. Both the experience of the Ebola virus disease outbreak in west Africa and the COVID-19 pandemic show how rapidly the spread of a disease can disrupt regional and global travel, trade, and other links.
    The Democratic Republic of the Congo has experienced 15 outbreaks of the disease in the past five decades. The largest outbreak occurred in August, 2018, in Nord Kivu and Ituri provinces (areas affected by armed conflicts), with 3740 cases reported including 2287 deaths—a case-fatality rate of 61%.
    The fourth and fifth Ebola virus disease outbreaks in the Democratic Republic of the Congo occurred in Mweka and Luebo in 2007 (264 cases reported) and in 2009 (32 cases reported). Kasai province is located in the south‑central part of the country, is made up of 18 health zones, and is bordered by seven provinces (Kwilu, Kwango, Sankuru, Tshuapa, Maindombe, Kasai Central, and Kasai Oriental) and one country (Angola) (appendix p 1).
    On Sept 4, 2025, the National Institute for Biomedical Research tested three samples from patients meeting the case definition of acute haemorrhagic fever, in Bulape health zone (which comprises five health areas), Kasai province, which were found to be positive for Ebola virus (Orthoebolavirus zairense). As of Sept 14, 2025, 35 confirmed cases have been reported, including 16 deaths (case-fatality rate 45·7%). Five health-care workers are among the confirmed cases. The index case is a 34-year-old pregnant woman who presented to the Bulape General Reference Hospital on Aug 20, 2025, with acute haemorrhagic syndrome, and died on Aug 25, 2025. Bulape is so far the only health zone affected. The neighbouring health zones of Mweka, Kakenge, and Mushenge reported suspected cases, but these all tested negative for Ebola virus.
    On Sept 2, 2025, following notification of suspected viral haemorrhagic fever cases, the Democratic Republic of the Congo Ministry of Health and WHO deployed the first rapid response team of experts, and shipped two tonnes of medical supplies and a mobile diagnostic laboratory, to Bulape health zone and its neighbouring health zone of Mweka in Kasai province. The first rapid response teams reached Mweka on Sept 4, 2025, and Bulape on Sept 5, 2025; these deployments were followed by those of other partners such as UNICEF, Médecins sans Frontières, and The Alliance for International Medical Action.
    On Sept 5, 2025, WHO graded the outbreak as a grade 3 public health emergency, involving the WHO headquarters and Regional Office for Africa in support to strengthen the country's outbreak response capacity. A summary of the timeline of the outbreak, as of Sept 5, 2025, is shown in the appendix (p 7).
    Vaccination of front-line health-care workers, contacts, and contacts of contacts started on Sept 13, 2025.
    The current confirmed Ebola virus disease outbreak is occurring in a province that shares borders with seven provinces and Angola. Tshikapa, the capital city of Kasai, is accessible from the national capital, Kinshasa, by air (two to three flights a week) and by 650 km of road. Mweka is 278 km from Tshikapa and accessible only by road. The distance between Mweka and Bulape is 27 km; poor road conditions make this a journey of around 12 h. However, despite limited accessibility, there is a high risk for the disease to spread outside Kasai province, especially to neighbouring provinces and Angola. Preventing cross-border spread requires urgent, rapid, and effective surveillance at points of entry to Kasai province, as well as preparedness measures in neighbouring areas.
    Kasai province has not experienced an Ebola virus disease outbreak for more than 15 years. The consequent lack of experience in managing Ebola virus disease outbreaks, coupled with a fragile health system, makes the province poorly prepared to respond effectively to this epidemic. This has been evidenced at the beginning of the outbreak by a shortage of personal protective equipment for case management and safe burials, as well as inadequate infection, prevention, and control measures.
    Ring vaccination for contacts, contacts of contacts, and front-line health-care workers has been one of the response strategies implemented in the last six Ebola virus disease outbreaks (in Equateur, Nord Kivu, and Ituri provinces) and has proven effective. Fortunately, the country had a stockpile of 2000 doses of the Ervebo vaccine, which was prepositioned in Kinshasa and quickly moved to Kasai.
    It is crucial that the Democratic Republic of the Congo Ministry of Health and international partners rapidly control this Ebola virus disease outbreak to prevent regional and international spread. Lessons learned from response to previous disease outbreaks have shown that the following are essential: (1) conduct a detailed outbreak investigation, including retrospective active case finding back to early July, focusing on health facilities and health areas with reported cases, as well as contact tracing in Bulape and neighbouring health zones; (2) strengthen infection, prevention, and control measures in all heath-care facilities, in communities, and at points of entry in Bulape and neighbouring health zones; (3) use experienced organisations, such as Médecins Sans Frontières and The Alliance for International Medical Action, for effective case management; (4) invest heavily in community engagement to counter misinformation and prevent community resistance, particularly against transfer of people with suspected infection to treatment centres and against safe and dignified burials; leverage the experience of the city of Beni during the tenth outbreak in setting up local committees in each health area that include community leaders to support outbreak response; (5) immediately start ring vaccination of contacts, contacts of contacts, and front-line health-care workers; (6) institute a data and modelling team to better inform decisions aimed at improving the effectiveness of outbreak response, as was done during the tenth outbreak; and (7) ensure that all response to the Ebola virus disease outbreak strengthens affected health-care systems to institutionalise outbreak preparedness and response measures.
    This Correspondence is intended to serve as an alert to the global community. We must not forget the lessons learned from decades of response to disease outbreaks and emergencies in the WHO African region, and from the COVID-19 pandemic, namely, the importance of high-level leadership, collaboration, and partnership.